|

Midazolam Clinical Trials

9 actively recruiting trials across 4 locations

Also known as: Dormicum, Hypnovel, Randomized Controlled Phase Intervention 2, Seizalam

Pipeline

Phase 1: 2Phase 2: 1Phase 3: 2Phase 1/2: 1

Top Sponsors

  • Yangzhou University1
  • University Hospital, Montpellier1
  • Pfizer1
  • Medical University of Vienna1
  • Kura Oncology, Inc.1

Indications

  • Anxiety3
  • Cancer3
  • Multiple Sclerosis Fatigue1
  • Remimazolam1
  • Coronary Artery Bypass Grafting1

Other5 trials

Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia
Phase 3
Intraoperative Midazolam on Delirium Outcome of Elderly Patients
Phase 1
Ketamine in OCD: Efficacy and Effects on Stress and Cognition
N/A
Remimazolam for Postoperative Atrial Fibrillation
N/A
The Effects of Different Anesthetics on Functional Connectivity
N/A

Gilbert, Arizona1 trial

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Banner MD Anderson Cancer Center

Phase 1/2

Fayetteville, Arkansas1 trial

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Highlands Oncology Group

Phase 1

Atlanta, Georgia1 trial

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Peachford Hospital-Atlanta Behavioral Research

Phase 3

Baltimore, Maryland1 trial

Ketamine for Multiple Sclerosis Fatigue

Johns Hopkins University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.